Linnaeus Therapeutics, Inc., 2026-11-18
A new SEC Form D private-offering notice from Haddonfield, NJ, a $10,000,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Clinical-stage biopharmaceutical company developing GPER-targeted small molecule therapeutics for cancer, cardiometabolic disease and healthy aging
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Elligint Health, Inc., 2026-11-19, $7.5M, Edison, NJ
- Mosaic Biosciences, Inc., 2026-11-19, $3M, Boulder, CO
- Sensetics, Inc., 2026-11-17, $10M, Princeton, NJ
- INFLAMMATIX, INC., 2026-11-19, $57.3M, Sunnyvale, CA
- Lyzr, Inc., 2026-11-17, $33.9M, Jersey City, NJ
- Laza Medical, Inc., 2026-11-19, $115M, Campbell, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.